| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.17 | 0.006 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.006 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.008 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.008 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.009 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |